Covered recipient · General Payments record
LYDIA N GREFFET
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2023–2024
$1,134.32
- Reported across 62 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $445.35 | 29 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $245.33 | 18 |
| Acerta Pharma LLC | $49.72 | 3 |
| Phathom Pharmaceuticals, Inc. | $32.02 | 2 |
| Lilly USA, LLC | $24.72 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $20.46 | 1 |
| Novo Nordisk AS | $19.28 | 1 |
| Axsome Therapeutics, Inc. | $18.90 | 1 |
| Amgen Inc. | $17.77 | 1 |
| GlaxoSmithKline, LLC. | $17.15 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (29)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $8.55 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107252177 | CMS |
| ABBVIE INC. | $9.19 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107252179 | CMS |
| ABBVIE INC. | $16.97 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107252181 | CMS |
| ABBVIE INC. | $9.14 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107252183 | CMS |
| ABBVIE INC. | $23.23 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107252185 | CMS |
| ABBVIE INC. | $8.24 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107252187 | CMS |
| ABBVIE INC. | $88.23 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107252189 | CMS |
| ABBVIE INC. | $6.79 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107252191 | CMS |
| ABBVIE INC. | $29.45 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107252193 | CMS |
| ABBVIE INC. | $6.13 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107252195 | CMS |
| ABBVIE INC. | $5.17 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107252197 | CMS |
| ABBVIE INC. | $6.92 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107252199 | CMS |
| ABBVIE INC. | $1.62 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107252201 | CMS |
| ABBVIE INC. | $2.68 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107252203 | CMS |
| ABBVIE INC. | $5.36 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107252205 | CMS |
| ABBVIE INC. | $6.01 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107252207 | CMS |
| ABBVIE INC. | $6.58 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107252209 | CMS |
| ABBVIE INC. | $5.07 | 12/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107252211 | CMS |
| Amgen Inc. | $17.77 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117567624 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.54 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105576328 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.15 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104775028 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.03 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105894856 | CMS |
| Axsome Therapeutics, Inc. | $18.90 | 01/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148386836 | CMS |
| GlaxoSmithKline, LLC. | $17.15 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116258217 | CMS |
| Lilly USA, LLC | $24.72 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135827487 | CMS |
| Novartis Pharmaceuticals Corporation | $20.46 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086819321 | CMS |
| Novo Nordisk Inc | $19.28 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100489513 | CMS |
| Phathom Pharmaceuticals, Inc. | $15.92 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151169950 | CMS |
| Phathom Pharmaceuticals, Inc. | $16.10 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151169952 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.